| Steven Ciglar, MD | |
|
300 Rockefeller Dr, Muskogee, OK 74401-5075 | |
| (918) 682-5501 | |
| Not Available |
| Full Name | Steven Ciglar |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 21 Years |
| Location | 300 Rockefeller Dr, Muskogee, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336334671 | NPI | - | NPPES |
| 200194050A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 24100 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hillcrest Medical Center | Tulsa, OK | Hospital |
| Hillcrest Hospital South | Tulsa, OK | Hospital |
| Bailey Medical Center, Llc | Owasso, OK | Hospital |
| Hillcrest Hospital Claremore | Claremore, OK | Hospital |
| Wagoner Community Hospital | Wagoner, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tulsa X-ray Laboratory Inc | 4183537426 | 21 |
News Archive
The American Association of Neuroscience Nurses (AANN) and Association for Rehabilitation Nurses (ARN) are proud to announce the newest addition to the respected AANN Clinical Practice Guideline series, Care of the Patient with Mild Traumatic Brain Injury.
Anxiety disorders appear to be independently associated with several physical conditions, including thyroid disease, respiratory disease, arthritis and migraine headaches, according to a report in the October 23 issue of Archives of Internal Medicine. This co-occurrence of disorders may significantly increase the risk of disability and negatively affect quality of life.
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported the successful results of its Phase 2b trial for once-daily, quadruple-action RoclatanTM, a combination of Aerie's triple-action RhopressaTM with latanoprost, a prostaglandin analogue (PGA).
Working with human breast cancer cells, a team of scientists from Ann & Robert H. Lurie Children's Hospital of Chicago have successfully turned off a misbehaving protein that fuels the growth of a particularly aggressive, drug-resistant form of the disease known as triple-negative breast cancer.
› Verified 7 days ago
| Entity Name | Tulsa X-ray Laboratory Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144211582 PECOS PAC ID: 4183537426 Enrollment ID: O20031111000899 |
News Archive
The American Association of Neuroscience Nurses (AANN) and Association for Rehabilitation Nurses (ARN) are proud to announce the newest addition to the respected AANN Clinical Practice Guideline series, Care of the Patient with Mild Traumatic Brain Injury.
Anxiety disorders appear to be independently associated with several physical conditions, including thyroid disease, respiratory disease, arthritis and migraine headaches, according to a report in the October 23 issue of Archives of Internal Medicine. This co-occurrence of disorders may significantly increase the risk of disability and negatively affect quality of life.
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported the successful results of its Phase 2b trial for once-daily, quadruple-action RoclatanTM, a combination of Aerie's triple-action RhopressaTM with latanoprost, a prostaglandin analogue (PGA).
Working with human breast cancer cells, a team of scientists from Ann & Robert H. Lurie Children's Hospital of Chicago have successfully turned off a misbehaving protein that fuels the growth of a particularly aggressive, drug-resistant form of the disease known as triple-negative breast cancer.
› Verified 7 days ago
| Entity Name | Eagle Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548450976 PECOS PAC ID: 9032205752 Enrollment ID: O20071011000078 |
News Archive
The American Association of Neuroscience Nurses (AANN) and Association for Rehabilitation Nurses (ARN) are proud to announce the newest addition to the respected AANN Clinical Practice Guideline series, Care of the Patient with Mild Traumatic Brain Injury.
Anxiety disorders appear to be independently associated with several physical conditions, including thyroid disease, respiratory disease, arthritis and migraine headaches, according to a report in the October 23 issue of Archives of Internal Medicine. This co-occurrence of disorders may significantly increase the risk of disability and negatively affect quality of life.
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported the successful results of its Phase 2b trial for once-daily, quadruple-action RoclatanTM, a combination of Aerie's triple-action RhopressaTM with latanoprost, a prostaglandin analogue (PGA).
Working with human breast cancer cells, a team of scientists from Ann & Robert H. Lurie Children's Hospital of Chicago have successfully turned off a misbehaving protein that fuels the growth of a particularly aggressive, drug-resistant form of the disease known as triple-negative breast cancer.
› Verified 7 days ago
| Entity Name | Landmark Cancer Center Gp Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598102345 PECOS PAC ID: 1658506662 Enrollment ID: O20131029001312 |
News Archive
The American Association of Neuroscience Nurses (AANN) and Association for Rehabilitation Nurses (ARN) are proud to announce the newest addition to the respected AANN Clinical Practice Guideline series, Care of the Patient with Mild Traumatic Brain Injury.
Anxiety disorders appear to be independently associated with several physical conditions, including thyroid disease, respiratory disease, arthritis and migraine headaches, according to a report in the October 23 issue of Archives of Internal Medicine. This co-occurrence of disorders may significantly increase the risk of disability and negatively affect quality of life.
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported the successful results of its Phase 2b trial for once-daily, quadruple-action RoclatanTM, a combination of Aerie's triple-action RhopressaTM with latanoprost, a prostaglandin analogue (PGA).
Working with human breast cancer cells, a team of scientists from Ann & Robert H. Lurie Children's Hospital of Chicago have successfully turned off a misbehaving protein that fuels the growth of a particularly aggressive, drug-resistant form of the disease known as triple-negative breast cancer.
› Verified 7 days ago
| Entity Name | Genesiscare Landmark Oklahoma Cancer Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952914814 PECOS PAC ID: 2567870538 Enrollment ID: O20210413001692 |
News Archive
The American Association of Neuroscience Nurses (AANN) and Association for Rehabilitation Nurses (ARN) are proud to announce the newest addition to the respected AANN Clinical Practice Guideline series, Care of the Patient with Mild Traumatic Brain Injury.
Anxiety disorders appear to be independently associated with several physical conditions, including thyroid disease, respiratory disease, arthritis and migraine headaches, according to a report in the October 23 issue of Archives of Internal Medicine. This co-occurrence of disorders may significantly increase the risk of disability and negatively affect quality of life.
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported the successful results of its Phase 2b trial for once-daily, quadruple-action RoclatanTM, a combination of Aerie's triple-action RhopressaTM with latanoprost, a prostaglandin analogue (PGA).
Working with human breast cancer cells, a team of scientists from Ann & Robert H. Lurie Children's Hospital of Chicago have successfully turned off a misbehaving protein that fuels the growth of a particularly aggressive, drug-resistant form of the disease known as triple-negative breast cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven Ciglar, MD Po Box 2994, Kennesaw, GA 30156-9181 Ph: (770) 514-2773 | Steven Ciglar, MD 300 Rockefeller Dr, Muskogee, OK 74401-5075 Ph: (918) 682-5501 |
News Archive
The American Association of Neuroscience Nurses (AANN) and Association for Rehabilitation Nurses (ARN) are proud to announce the newest addition to the respected AANN Clinical Practice Guideline series, Care of the Patient with Mild Traumatic Brain Injury.
Anxiety disorders appear to be independently associated with several physical conditions, including thyroid disease, respiratory disease, arthritis and migraine headaches, according to a report in the October 23 issue of Archives of Internal Medicine. This co-occurrence of disorders may significantly increase the risk of disability and negatively affect quality of life.
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported the successful results of its Phase 2b trial for once-daily, quadruple-action RoclatanTM, a combination of Aerie's triple-action RhopressaTM with latanoprost, a prostaglandin analogue (PGA).
Working with human breast cancer cells, a team of scientists from Ann & Robert H. Lurie Children's Hospital of Chicago have successfully turned off a misbehaving protein that fuels the growth of a particularly aggressive, drug-resistant form of the disease known as triple-negative breast cancer.
› Verified 7 days ago
Selamawit Negusse, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 300 Rockefeller Dr, Muskogee, OK 74401 Phone: 918-684-2187 Fax: 918-684-2196 | |
Satyendra Arya, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 N. 32nd St., Muskogee, OK 74401 Phone: 918-683-2000 | |
Oana Madalina Mischiu, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1011 Honor Heights Dr, Muskogee, OK 74401 Phone: 918-683-3261 | |
Dr. Altaf Husain, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1011 Honor Heights Drive, Muskogee, OK 74401 Phone: 918-683-3261 | |
Dr. Heath Armstrong Vandelinder, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 300 Rockefeller Dr., Muskogee, OK 74401 Phone: 918-684-3480 |